Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fumidil B
1. 23110-15-8
2. Fugillin
3. Fumidil
4. Amebacilin
5. Fumagilline
6. Fumagillinum
7. Fumagilina
8. (-)-fumagillin
9. Zgn-201
10. Amebacillin
11. Fugilin
12. Chembl32838
13. 2,4,6,8-decatetraenedioic Acid, 4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2,5)oct-6-yl Ester
14. Fumagillin Dch
15. Chebi:48635
16. Nsc-9168
17. 7ow73204u1
18. Dsstox_cid_20736
19. Dsstox_rid_79580
20. Dsstox_gsid_40736
21. (2e,4e,6e,8e)-10-({(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]oct-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic Acid
22. Fumagillina
23. Flisint
24. (2e,4e,6e,8e)-10-(((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl)oxy)-10-oxodeca-2,4,6,8-tetraeno
25. Cas-23110-15-8
26. Fumagillina [dcit]
27. U 5762
28. Fumagilina [inn-spanish]
29. Fumagilline [inn-french]
30. Fumagillinum [inn-latin]
31. Nsc9168
32. Fumagillin [inn:ban:dcf]
33. Ccris 9025
34. Unii-7ow73204u1
35. Ncgc00163699-01
36. H-3
37. Nsc 9168
38. Einecs 245-433-8
39. Fumagillin [mi]
40. Fumagillin [inn]
41. Fumagillin [mart.]
42. Schembl8130
43. Fumagillin [who-dd]
44. Dtxsid7040736
45. Schembl15263952
46. (2e,4e,6e,8e)-mono[(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] 2,4,6,8-decatetraenedioic Acid Ester
47. Ex-a2890
48. Hy-b0751
49. Zinc4098264
50. Tox21_112066
51. Tox21_302410
52. Bdbm50113436
53. S7784
54. Akos024456768
55. Db02640
56. Lmpr0103060003
57. Ncgc00163699-02
58. Ncgc00163699-07
59. Ncgc00255568-01
60. Ac-35866
61. Bs-16576
62. Sr-90144
63. D81922
64. Q120199
65. (2e,4e,6e,8e)-10-(((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl)oxy)-10-oxodeca-2,4,6,8-tetraenoic Acid
66. 127913-45-5
67. 2,4,6,8-decatetraenedioic Acid, 1-((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (2e,4e,6e,8e)-
68. 2,4,6,8-decatetraenedioic Acid, Mono((3r,4s,5s,6r)-5-methoxy-4-((2r,3r)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (2e,4e,6e,8e)-
69. 2,4,6,8-decatetraenedioic Acid, Mono(4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2.5)oct-6-yl) Ester
70. 2,4,6,8-decatetraenedioic Acid, Mono(4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2.5)oct-6-yl) Ester (van)
71. 2,4,6,8-decatetraenedioic Acid, Mono(5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (3r- (3.alpha.,4.alpha.(2r*,3r*),5.beta.,6.beta.(2e,4e,6e,8e)))-
72. 2,4,6,8-decatetraenedioic Acid, Mono(5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl) Ester, (3r-(3alp
73. 2,4,6,8-decatetraenedioic Acid, Mono[(3r,4s,5s,6r)-5-methoxy-4-[(2r,3r)-2-methyl-3-(3-methyl-2-buten-1-yl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] Ester, (2e,4e,6e,8e)-
74. Antibiotic Obtained From Cultures Of Aspergillus Fumigatus, Or The Same Substance Produced By Any Other Means
| Molecular Weight | 458.5 g/mol |
|---|---|
| Molecular Formula | C26H34O7 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 458.23045342 g/mol |
| Monoisotopic Mass | 458.23045342 g/mol |
| Topological Polar Surface Area | 97.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 879 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Angiogenesis Inhibitors
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AX - Other agents against amoebiasis and other protozoal diseases
P01AX10 - Fumagillin
API SUPPLIERS
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Fumagillin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fumagillin, including repackagers and relabelers. The FDA regulates Fumagillin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fumagillin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fumagillin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fumagillin supplier is an individual or a company that provides Fumagillin active pharmaceutical ingredient (API) or Fumagillin finished formulations upon request. The Fumagillin suppliers may include Fumagillin API manufacturers, exporters, distributors and traders.
click here to find a list of Fumagillin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Fumagillin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fumagillin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fumagillin GMP manufacturer or Fumagillin GMP API supplier for your needs.
A Fumagillin CoA (Certificate of Analysis) is a formal document that attests to Fumagillin's compliance with Fumagillin specifications and serves as a tool for batch-level quality control.
Fumagillin CoA mostly includes findings from lab analyses of a specific batch. For each Fumagillin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fumagillin may be tested according to a variety of international standards, such as European Pharmacopoeia (Fumagillin EP), Fumagillin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fumagillin USP).
LOOKING FOR A SUPPLIER?
